Susquehanna International Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $875K | Buy |
42,853
+6,952
| +19% | +$142K | ﹤0.01% | 3468 |
|
|
2025
Q1 | $719K | Buy |
35,901
+18,467
| +106% | +$370K | ﹤0.01% | 3834 |
|
|
2024
Q4 | $465K | Buy |
+17,434
| New | +$465K | ﹤0.01% | 4174 |
|
|
2024
Q3 | – | Sell |
-35,979
| Closed | -$783K | – | 5790 |
|
|
2024
Q2 | $783K | Buy |
+35,979
| New | +$783K | ﹤0.01% | 2877 |
|
|
2024
Q1 | – | Sell |
-26,600
| Closed | -$574K | – | 5729 |
|
|
2023
Q4 | $574K | Buy |
+26,600
| New | +$574K | ﹤0.01% | 3649 |
|
|
2023
Q3 | – | Sell |
-11,551
| Closed | -$158K | – | 5685 |
|
|
2023
Q2 | $158K | Sell |
11,551
-166
| -1% | -$2.28K | ﹤0.01% | 4774 |
|
|
2023
Q1 | $266K | Buy |
+11,717
| New | +$266K | ﹤0.01% | 4549 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5978 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6231 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5943 |
|
|
2022
Q1 | – | Sell |
-10,707
| Closed | -$459K | – | 5862 |
|
|
2021
Q4 | $459K | Buy |
+10,707
| New | +$459K | ﹤0.01% | 3930 |
|
|
2021
Q3 | – | Sell |
-14,477
| Closed | -$1.06M | – | 5442 |
|
|
2021
Q2 | $1.06M | Sell |
14,477
-29,890
| -67% | -$2.19M | ﹤0.01% | 2895 |
|
|
2021
Q1 | $3.04M | Buy |
44,367
+19,783
| +80% | +$1.35M | ﹤0.01% | 1664 |
|
|
2020
Q4 | $1.65M | Buy |
+24,584
| New | +$1.65M | ﹤0.01% | 1935 |
|
|
2020
Q3 | – | Sell |
-11,773
| Closed | -$444K | – | 4497 |
|
|
2020
Q2 | $444K | Buy |
+11,773
| New | +$444K | ﹤0.01% | 3055 |
|